Build your base

Alienum phaedrum torquatos nec eu, vis detraxit periculis ex, nihil expetendis in mei. Mei an pericula euripidis, hinc partem ei est.
Back to top

Drug Development October 27-28, 2022 New Horizons in Pediatric
Countdown to Meeting

Pediatric Challenges, Big and Small

Pediatric drug development is at a critical juncture with growing regulatory demands and trial recruitment challenges. But there is exciting innovation today and in our horizon that will help us get crucial medicines to children faster. We invite you to join thought leaders from academia, industry, and health authorities during our 2nd annual New Horizons in Pediatric Drug Development Symposium. Our 2-day virtual event will focus on innovations that can help advance your pediatric drug development program in oncology, rare and infectious diseases.

Featured Speakers

We are excited to feature discussions led by key thought leaders in pediatric drug development from industry, regulatory agencies, and academia.
Brian Aylward

Brian Aylward, MD

Chair European Medicines Agency Paediatric Committee
Neil Sebire

Neil Sebire, MB BS, BClinSci MD

Professor & Chief Research Information Officer Great Ormond Street Hospital
Annagrazia Altavilla

Annagrazia Altavilla, PhD, HDR

Lawyer, TEDDYNETWORK Chair, Espace Ethique Paca-Corse
Krithika Shetty

Krithika Arun Shetty, PhD

Associate Director, Certara
Jeff Barrett

Jeff Barrett, PhD

Chief Science Officer, Aridhia DRE

Elly Barry, MD, MMSc

Head of Clinical Development, Day One Biopharmaceuticals
Adrie Bekker

Adrie Bekker, PhD, MD

Professor, Stellenbosch University
Sam Blackman

Samuel Blackman, PhD, MD

Founder & Chief Medical Officer Day One BIopharmaceuticals
Felix Boakye Agyeman

Felix Boakye-Agyeman, PhD, MD

Senior Director of Pharmacometrics, Certara
Julie Bullock

Julie Bullock, PharmD

Senior Vice President, Global Head of Clinical Pharmacology & Translational Medicine, Certara
Arthur Caplan

Arthur L. Caplan, PhD

Drs. William F and Virginia Connolly Mitty Chair Director, Division of Medical Ethics NYU Grossman School of Medicine
Amy Cheung

Amy Cheung, PhD

Senior Director of Integrated Drug Development, Certara
Glen Clack

Glen Clack, MB, BS, MD, FFPM

Professor of Translational Medicine, University of Manchester

Solange Corriol-Rohou, MD

Sr. Director of Regulatory Affairs & Policy for Europe, AstraZeneca
Lynne Georgopoulos

Lynne Georgopoulos, RN, MSHS, RAC

Vice President, Regulatory Strategy, Certara
Rachel Greenberg

Rachel G. Greenberg, MD, MHS

Neonatologist and Associate Professor of Pediatrics at Duke University Medical Center
Angela James

Angela James, PhD

Vice President, Head of Clinical Pharmacology, MacroGenics Inc.
Alice Ke

Alice Ke, PhD

Senior Director, PBPK, Certara
Maryna Kolochavina

Maryna Kolochavina, PharmD, PhD, PMP

Director, Five Voices Consortium
Kerry Jo Lee

Kerry Jo Lee, MD

Associate Director for Rare Diseases, US FDA, CDER
Jian LI

Jian Li, PhD

Professor Monash University, Australia
Brian Maas

Brian Maas, PharmD

Principal Scientist, Quantitative Pharmacology and Pharmacometrics
Dave Mitchell

Dave Mitchell, PhD

Senior Vice President, Strategic Engagement, Certara
Flora Musuamba

Flora Musuamba Tshinanu, PhD

Professor University of Namur
David Nobbs

David Nobbs, PhD

International Regulatory Policy Lead for Digital Health and Data Policy, Roche
Robert Nelson

Robert Nelson, MD, PhD

Senior Director, Pediatric Drug Development Johnson & Johnson
Lauren Price

Lauren Price, PharmD

Clinical Pharmacology Reviewer, US FDA, CDER
Leyla Sahin

Leyla Sahin, MD

US FDA, Center for Drug Evaluation and Research
Virna Schuck

Virna Schuck, PhD

VP, Head of Clinical Pharmacology, Ribon Therapeutics
Joe Standing

Joe Standing, PhD

Professor of Pharmacometrics Great Ormond Street Hospital for Children

Ashley Strougo, PhD

Childhood Cancer Program Lead, Sanofi
Isaac R. Rodriguez-Chavez

Isaac Rodriguez-Chavez, Ph.D., M.H.S., M.S.

SVP, Scientific & Clinical Affairs, Head, Center for DCTs & Digital Medicine, ICON plc

Karen Rowland Yeo, PhD

Senior Vice President of Client and Regulatory Strategy, Certara
Lionel Tan

Lionel Tan, MBBS, FRCP, PhD, DTM&H

ViiV Healthcare, Research and Development
John van den Anker

John van den Anker, MD, PhD

Division Chief, Clinical Pharmacology, Children's National Hospital
Lynne Yao

Lynne Yao, MD

Director at Division of Pediatric and Maternal Health at US FDA, CDER
James Yates

James Yates, MMath, PhD

Scientific Director GSK